NovoBind
Vancouver
About NovoBind
NovoBind is an integrated animal health company utilizing next-generation biologics to target and neutralize key pathogens affecting producers and food safety. They target pathogens that cause >$1B of production losses.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $30.0K
- Funding stage: Early Stage Venture
- Last round: Grant (Apr 2023)
- Website: novobind.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/novobind-153983 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.